Middle East & Africa Rapid Test Kit Market Forecast to 2030 - Regional Analysis - by Type, Product, Technology, Application, and End User

Description

List of Tables

The Middle East & Africa rapid test kit market was valued at US$ 849.64 million in 2022 and is expected to reach US$ 1,174.76 million by 2030; it is estimated to record a CAGR of 4.1% from 2022 to 2030.

Innovations in Rapid Antigen Tests Boost Middle East & Africa Rapid Test Kit Market

Operations of multiplex rapid antigen tests are based on multicolored nanoparticles and cross-reactive antibodies, and these test kits can be developed at low costs. When various respiratory pathogens are circulating simultaneously in a host body, rapid multiplex diagnostic testing helps healthcare providers supervise their patients with greater effectiveness. These tests can help avoid misdiagnosis that is possible due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, they help healthcare providers make apt decisions about the commencement and discontinuation of antimicrobial therapies. Compared to single specimen antigen tests kits, multiplex rapid antigen tests kits can detect many respiratory viruses from a single specimen, without compromising on the quality of results. Thus, innovations such as multiplex rapid antigen tests are emerging as future trends in the rapid test kits market.

Middle East & Africa Rapid Test Kit Market Overview

The Saudi Arabia rapid test kits market is growing at a fast pace, driven by a huge population base and the increase in the prevalence of infectious diseases. According to WHO, influenza and pneumonia deaths reached 4.58% of total deaths in the country. To address the growing number of influenza cases, the Public Health Laboratory in Saudi Arabia fulfilled all the requirements by WHO to be recognized as a national influenza center for Saudi Arabia. According to Gulf News, 3,367 people were infected with malaria in Saudi Arabia in 2020.

According to the International Diabetes Federation (IDF), in Saudi Arabia, the total cases of diabetes in adults was 4.27 million in 2021. Thus, the growing cases of diabetes is anticipated to propel the growth of the rapid test kits market in the country.

Middle East & Africa Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Rapid Test Kit Market Segmentation

The Middle East & Africa rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Middle East & Africa rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Middle East & Africa rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Middle East & Africa rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Middle East & Africa rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Middle East & Africa rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Middle East & Africa rapid test kit market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, Guangzhou Wondfo Biotech Co Ltd, Abbott Laboratoriess, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Middle East & Africa rapid test kit market.

Product Code: BMIRE00030472

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Middle East & Africa Rapid Test Kits Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
- 4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
- 4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
- 4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
- 4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis

5. Rapid Test Kits Market - Middle East & Africa Market Analysis

5.1 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030

6. Middle East & Africa Rapid Test Kits Market Analysis - by Type

6.1 Overview
6.2 Rapid Antigen Testing
- 6.2.1 Overview
- 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
- 6.3.1 Overview
- 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

7. Middle East & Africa Rapid Test Kits Market Analysis - by Product

7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
- 7.2.1 Overview
- 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
- 7.3.1 Overview
- 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Rapid Test Kits Market Analysis - by Technology

8.1 Overview
8.2 Lateral Flow Assay
- 8.2.1 Overview
- 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
- 8.3.1 Overview
- 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
- 8.4.1 Overview
- 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
- 8.5.1 Overview
- 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
- 8.6.1 Overview
- 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Rapid Test Kits Market Analysis - by Application

9.1 Overview
9.2 Blood Glucose Testing
- 9.2.1 Overview
- 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
- 9.3.1 Overview
- 9.3.2 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
- 9.4.1 Overview
- 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
- 9.5.1 Overview
- 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Rapid Test Kits Market Analysis - by End User

10.1 Overview
10.2 Hospital and Clinics
- 10.2.1 Overview
- 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
- 10.4.1 Overview
- 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)

11. Middle East & Africa Rapid Test Kits Market - Country Analysis

11.1 Middle East & Africa
- 11.1.1 Overview
- 11.1.2 Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
  - 11.1.2.1 Saudi Arabia
    - 11.1.2.1.1 Overview
  - 11.1.2.2 Saudi Arabia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.2.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.2.2 Saudi Arabia: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.2.3 Saudi Arabia: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.2.4 Saudi Arabia: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.2.4.1 Saudi Arabia: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.2.5 Saudi Arabia: Rapid Test Kits Market Breakdown, by End User
  - 11.1.2.3 South Africa
    - 11.1.2.3.1 Overview
  - 11.1.2.4 South Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.4.1 South Africa: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.4.2 South Africa: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.4.3 South Africa: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.4.4 South Africa: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.4.4.1 South Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.4.5 South Africa: Rapid Test Kits Market Breakdown, by End User
  - 11.1.2.5 United Arab Emirates
    - 11.1.2.5.1 Overview
  - 11.1.2.6 United Arab Emirates: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.6.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.6.2 United Arab Emirates: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.6.3 United Arab Emirates: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.6.4 United Arab Emirates: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.6.4.1 United Arab Emirates: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.6.5 United Arab Emirates: Rapid Test Kits Market Breakdown, by End User
  - 11.1.2.7 Rest of Middle East & Africa
    - 11.1.2.7.1 Overview
  - 11.1.2.8 Rest of Middle East & Africa: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.1.2.8.1 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Type
    - 11.1.2.8.2 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Product
    - 11.1.2.8.3 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Technology
    - 11.1.2.8.4 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Application
    - 11.1.2.8.4.1 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
    - 11.1.2.8.5 Rest of Middle East & Africa: Rapid Test Kits Market Breakdown, by End User

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
- 12.3.1 Overview
12.4 Organic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ARKRAY Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Fujirebio Europe NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cepheid
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 QIAGEN NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Guangzhou Wondfo Biotech Co Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Abbott Laboratories
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Hologic Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 DiaSorin SpA
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 Premier Medical Corp Pvt Ltd
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Beckman Coulter Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments

14. Appendix

14.1 About The Insight Partners